【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 11
1.2 List of Figures 14
2 Introduction 15
2.1 Catalyst 15
3 Alzheimer’s Disease Overview 16
3.1 Continuum of AD – Preclinical, MCI and AD Dementia 16
3.1.1 Preclinical AD 17
3.1.2 MCI 18
3.1.3 AD Dementia 19
3.2 Etiology and Pathophysiology 19
3.2.1 Etiology 19
3.2.2 Pathophysiology 22
4 AD Biomarkers – Overview 34
4.1 What are Biomarkers? 34
4.2 Criteria for Good Biomarkers 35
4.2.1 Sensitivity and Specificity of Biomarkers 36
4.3 Role of Biomarkers in AD Diagnosis 37
4.3.1 Challenges in Establishing AD Biomarkers as Diagnostic Tools 38
4.4 Role of Biomarkers in Drug Development 38
4.5 Biomarker Development and Validation 41
4.6 Classes of AD Biomarkers by Pathophysiological Mechanism 42
4.6.1 Temporal Evolution of Biomarkers 44
5 Unmet Needs Assessment 47
5.1 Overview 47
5.2 Unmet Needs Analysis 48
5.2.1 Patient and Physician Knowledge/Awareness of AD Diagnosis 48
5.2.2 Generalized Biomarker Unmet Needs 51
5.2.3 Unmet Need for Diverse Types of Biomarkers 54
6 AD Biomarkers Market Drivers and Barriers 59
6.1 Driver: Increasing prevalence of AD corresponding to a growth in the aging population will rapidly expand the biomarker market size 59
6.2 Driver: Anticipated future cost of biologic AD treatments will drive the use of biomarker diagnostics 60
6.3 Driver: Favorable regulatory standards for the application of biomarkers in drug discovery 61
6.4 Barrier: Present lack of disease-modifying treatments hinders the use of diagnostic tests 61
6.5 Barrier: Rigorous, expensive, and time-consuming nature of biomarker development and validation 62
6.6 Barrier: Reimbursement restrictions for diagnostic testing 63
6.7 Barrier: Healthcare system and physician practice barriers limit patient referral to specialists and the use of biomarker tests 63
7 Amyloid Beta Biomarkers 66
7.1 Overview of Biomarker Class 66
7.2 Drug Therapies Targeting Amyloid Beta 67
7.2.1 Overview 67
7.2.2 Representative Pipeline Drugs 67
7.3 Amyloid Biomarker Assays 69
7.3.1 Amyloid PET-Imaging 69
7.3.2 CSF-Based Amyloid Assays 80
7.3.3 Other Amyloid Assays in Development 87
8 Tau-Related Biomarkers 90
8.1 Overview of Biomarker Class 90
8.2 Drug Therapies Targeting Tau 90
8.2.1 Overview 90
8.2.2 Representative Products 90
8.3 Tau Biomarker Assays 92
8.3.1 CSF-Based Tau Assays 93
8.3.2 Promising Pipeline Products – Tau PET Imaging Ligands 98
9 Beyond Amyloid and Tau: Other Molecular AD Biomarkers in Development 100
9.1 Overview 100
9.1.1 Neuronal and Synaptic Degeneration 100
9.1.2 Inflammation and Oxidative Stress 101
9.2 Promising Pipeline Products 104
9.2.1 Alzheimer’s CSF 16-Plex Assay (Proteome Sciences) 104
9.3 Blood-Based Biomarkers 105
9.3.1 Overview 105
9.3.2 Promising Pipeline Products 107
10 Functional Brain Imaging Biomarkers 114
10.1 Overview of Biomarker Class 114
10.2 Functional Brain Imaging Assays 114
10.2.1 FDG-PET 115
10.2.2 FMRI Biomarkers of AD 118
11 Structural Brain Imaging Biomarkers 123
11.1 Overview of Biomarker Class 123
11.2 Structural Brain Imaging Assays 124
11.2.1 MRI Hippocampal Volumetry 125
11.2.2 Other Structural Imaging Biomarkers in Pipeline Development 128
12 Regulatory Considerations Impacting AD Biomarkers 130
12.1 Clinical Trial Design in AD Drug Development 130
12.1.1 Regulatory Agency Recommendations 133
12.1.2 Key Opinion Leaders on the Use of Biomarkers in Drug Clinical Trials 134
12.1.3 Mapping the Use of Biomarkers in Key AD Drug Clinical Trials 139
12.1.4 AD Drug Approval, Population or Stage-Specific Indications, and Off-Label Use 140
12.2 Reimbursement of Biomarker-Based Testing 141
12.2.1 Concerns Limiting Reimbursement of Biomarker Testing for AD 141
12.2.2 Region-Specific Differences in Biomarker Test Reimbursement Policies and Pathways in the US and EU 145
13 Outlook and Opportunities for AD Biomarkers 148
13.1 Overview 148
13.2 Key Players, Partnerships, and Associations 150
13.2.1 National and International AD Biomarkers Consortia 151
13.2.2 Private Industry Biomarker Partnerships 152
13.3 Opportunity Analysis 153
13.3.1 Opportunity: Biomarkers to Determine Appropriate Use of Treatment 154
13.3.2 Opportunity: Biomarkers as Populations Screens for Alzheimer’s Disease 155
13.3.3 Opportunity: Continued Development of Varied Biomarkers of Pathophysiology 155
14 Appendix 156
14.1 Bibliography 156
14.2 Abbreviations 170
14.3 Research Methodology 174
14.4 Physicians and Specialists Included in this Study 175
14.5 About the Authors 176
14.5.1 Authors 176
14.5.2 Global Head of Healthcare 177
14.6 About GlobalData 178
14.7 Disclaimer 178
【レポート販売概要】
■ タイトル:PharmaFocus: Biomarkers in Alzheimer’s Disease■ 英文:PharmaFocus: Biomarkers in Alzheimer’s Disease
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161287
■ 調査対象地域:グローバル
- タンクレベルモニタリングシステムの世界市場:フロート/テープゲージング式、圧力式、超音波式、静電容量式、レーダー式レベルモニタリング装置Tank level monitoring systems (TLMSs) have applications across varied industry verticals, such as oil & fuel, chemical, mining, agriculture & husbandry, and automotive. The oil & fuel vertical is anticipated to be the leading application segment of the tank level monitoring system market. The global tank level monitoring system market is primarily driven by the lower installation cost of these sys …
- ナイトビジョンシステム(暗視装置)の世界市場2017-2021About Night Vision Systems Night vision devices, with the help of different lenses, enable users seeing objects in the low-light conditions such as moonlight, starlight, and infrared (IR) light. Photocathode tubes convert photons of light into electrons. Electrons are then converted to visible light by throwing them against a phosphorous screen. Hence, it makes objects visible even in a dark envir …
- 重症急性呼吸器症候群(SARS)コロナウイルス感染症(SARS Coronavirus Infection):世界の治験レビュー2014年下半期版Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014" provides data on the Severe Acute Respiratory Syndrome (SARS) clinical trial scenario. This report provides elemental information and data relating …
- CEZ, a.s.:発電所及びSWOT分析2013CEZ, a.s. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and detailed …
- 内分泌検査の世界市場:臨床化学技術、免疫アッセイ技術、モノクローナル抗体/リクローナル抗体技術、タンデム質量分析技術、センサー技術About Endocrine Testing Systems Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of con …
- 花粉アレルギー(Pollen Allergy):治療薬開発パイプライン動向(2015年上半期版)Pollen Allergy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Pollen Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ( …
- 自動車用アルミニウムの世界市場予測(~2026):製品形態別(鋳造アルミニウム、圧延アルミニウム、押出アルミニウム)、用途別(伝動機構、車台・車体懸架装置、車体)、車両種類別(乗用車、小型商用車、重型商用車)、地域別“The automotive aluminum market is projected to grow at a CAGR of 8.8% from 2016 to 2026, in terms of value.” The automotive aluminum market is projected to reach USD 111.80 billion by 2026, at a CAGR of 8.8% from 2016 to 2026. Aluminum offers various performance benefits as it is light in weight and is more rigid as compared to steel, which makes it preferred material for automotive manufacturers …
- 信号発生装置の世界市場:任意波形発生器、RF発生装置、マイクロ波発生装置、映像信号発生器、オーディオ信号発生器、ファンクションジェネレータSignal generators are used to generate complex real time signals for real world applications in testing and measurement. A signal generator provides an accurate calibrated range of simple repetitive waveforms or acts as a single shot triggering source in case of arbitrary waveform generators. The signal from a signal generator can be adjusted in accordance with the frequency, output voltage, imped …
- 世界のヘリコプター市場動向(2014-2018)TechNavio's analysts forecast the Global Helicopter market to grow at a CAGR of 2.60 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand from civil end-users. The Global Helicopter market has also been witnessing the increase in high-altitude and versatile helicopters. However, the falling global defense budgets could pose a challenge …
- 駐車予約システムの世界市場Today, several parking problems are faced, considering the rise in vehicles and the difficulty to find empty spaces. This has also led to unruly traffic management. However, parking reservation systems streamline the entire parking process, comprising parking payments that is buying tickets or using prepaid cards to park the vehicles within the timeline, maintaining a comprehensive record of vehic …
- Acute Pain:グローバル臨床試験レビューH2, 2013Acute Pain Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Acute Pain Global Clinical Trials Review, H2, 2013" provides data on the Acute Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Pain. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 重症筋無力症治療薬の世界市場2017-2021:抗コリンエステラーゼ薬、免疫抑制剤、免疫グロブリン静注療法(IVIg)About Myasthenia Gravis Drugs Currently, the myasthenia gravis drugs market stands at a small size due to limited availability of approved therapies for the complete remission of the disease. However, the anticipated approval of novel drugs such as monoclonal antibodies should help market witness strong growth during the forecast period. For instance, Alexion Pharmaceuticals is currently developin …
- 単結晶シリコンの世界市場2018-2022About Monocrystalline Silicon Monocrystalline silicon, also known as single-crystal silicon, is made of pure silicon in an ordered and continuous single crystal structure. It is generally used as a light absorbing material in photovoltaic applications. Technavio’s analysts forecast the global monocrystalline silicon market to grow at a CAGR of 8.91% during the period 2018-2022. Covered in this rep …
- ダイボンダー装置の世界市場2017-2021ABSTRACTAbout Die Bonder Equipment Die bonder equipment are a type of semiconductor packaging and assembly equipment in which wafers are cut into dies, and the functional dies are separated from the defective ones, which are already marked before this step. bonder equipment are a type of semiconductor packaging and assembly equipment in which wafers are cut into dies, and the functional dies are s …
- 自動車用HVACのインド市場:技術別、車種別HVAC is the technology that is used for automotive cabin comfort. It can also be used to facilitate and manage the favorable and pleasant conditions inside the cabin by controlling the degree of the temperature. The basic operation of the HVAC system is convection and conduction. Heat is transferred from the region of low-temperature to the region of high-temperature in the vehicle due to pressure …